Format
Sort by
Items per page

Send to

Choose Destination

Best matches for frontotemporal dementia:

Frontotemporal Dementia. Olney NT et al. Neurol Clin. (2017)

[Frontotemporal dementia]. Johannsen P et al. Ugeskr Laeger. (2017)

Frontotemporal dementia. Bang J et al. Lancet. (2015)

Search results

Items: 1 to 20 of 7986

1.

Factors that predict diagnostic stability in neurodegenerative dementia.

Perry DC, Datta S, Miller ZA, Rankin KP, Gorno-Tempini ML, Kramer JH, Rosen HJ, Seeley WW, Miller BL.

J Neurol. 2019 May 17. doi: 10.1007/s00415-019-09362-5. [Epub ahead of print]

PMID:
31102021
2.

Food knowledge depends upon the integrity of both sensory and functional properties: a VBM, TBSS and DTI tractography study.

Vignando M, Aiello M, Rinaldi A, Cattarruzza T, Mazzon G, Manganotti P, Eleopra R, Rumiati RI.

Sci Rep. 2019 May 15;9(1):7439. doi: 10.1038/s41598-019-43919-8.

3.

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Siedlecki-Wullich D, Català-Solsona J, Fábregas C, Hernández I, Clarimon J, Lleó A, Boada M, Saura CA, Rodríguez-Álvarez J, Miñano-Molina AJ.

Alzheimers Res Ther. 2019 May 15;11(1):46. doi: 10.1186/s13195-019-0501-4.

4.

VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology.

Jang H, Jang ER, Wilson PG, Anderson D, Galperin E.

Mol Biol Cell. 2019 May 15:mbcE19030144. doi: 10.1091/mbc.E19-03-0144. [Epub ahead of print]

PMID:
31091164
5.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kremers WK, Kukull WA, Litvan I, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Kramer JH, Rosen HJ; ARTFL/LEFFTDS consortium.

Alzheimers Dement. 2019 May 11. pii: S1552-5260(19)30044-5. doi: 10.1016/j.jalz.2019.01.012. [Epub ahead of print]

PMID:
31088775
6.

C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo.

Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, Yao WD, Almeida S, Gao FB.

Nat Neurosci. 2019 May 13. doi: 10.1038/s41593-019-0397-0. [Epub ahead of print]

PMID:
31086314
7.

Emotion regulation via visual avoidance: Insights from neurological patients.

Otero MC, Levenson RW.

Neuropsychologia. 2019 May 10. pii: S0028-3932(18)30567-0. doi: 10.1016/j.neuropsychologia.2019.05.003. [Epub ahead of print]

PMID:
31082398
8.

Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways.

Liou CJ, Tong M, Vonsattel JP, de la Monte SM.

ASN Neuro. 2019 Jan-Dec;11:1759091419839515. doi: 10.1177/1759091419839515.

PMID:
31081340
9.

A novel mechanism for ATP to enhance the functional oligomerization of TDP-43 by specific binding.

Wang L, Lim L, Dang M, Song J.

Biochem Biophys Res Commun. 2019 May 9. pii: S0006-291X(19)30874-5. doi: 10.1016/j.bbrc.2019.05.006. [Epub ahead of print]

PMID:
31079926
10.

Analyzing theory of mind impairment in patients with behavioral variant frontotemporal dementia.

Giovagnoli AR, Bell B, Erbetta A, Paterlini C, Bugiani O.

Neurol Sci. 2019 May 11. doi: 10.1007/s10072-019-03911-6. [Epub ahead of print]

PMID:
31079279
11.

Segmentation of medial temporal subregions reveals early right-sided involvement in semantic variant PPA.

Bocchetta M, Iglesias JE, Russell LL, Greaves CV, Marshall CR, Scelsi MA, Cash DM, Ourselin S, Warren JD, Rohrer JD.

Alzheimers Res Ther. 2019 May 10;11(1):41. doi: 10.1186/s13195-019-0489-9.

12.

Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection.

Adaikkan C, Middleton SJ, Marco A, Pao PC, Mathys H, Kim DN, Gao F, Young JZ, Suk HJ, Boyden ES, McHugh TJ, Tsai LH.

Neuron. 2019 May 2. pii: S0896-6273(19)30346-0. doi: 10.1016/j.neuron.2019.04.011. [Epub ahead of print]

PMID:
31076275
13.

A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia.

Ash S, Nevler N, Phillips J, Irwin DJ, McMillan CT, Rascovsky K, Grossman M.

Brain Lang. 2019 May 6;194:46-57. doi: 10.1016/j.bandl.2019.04.006. [Epub ahead of print]

PMID:
31075725
14.

Suppression of Conditional TDP-43 Transgene Expression Differentially Affects Early Cognitive and Social Phenotypes in TDP-43 Mice.

Silva PR, Nieva GV, Igaz LM.

Front Genet. 2019 Apr 24;10:369. doi: 10.3389/fgene.2019.00369. eCollection 2019.

15.

Von Economo neurons are part of a larger neuronal population that are selectively vulnerable in C9orf72 frontotemporal dementia.

Gami-Patel P, van Dijken I, van Swieten JC, Pijnenburg YAL, Brain Bank N, Rozemuller AJM, Hoozemans JJM, Dijkstra AA.

Neuropathol Appl Neurobiol. 2019 May 7. doi: 10.1111/nan.12558. [Epub ahead of print]

PMID:
31066065
16.

Frontotemporal asymmetry in socioemotional behavior: A pilot study in frontotemporal dementia.

Carr AR, Jimenez EE, Thompson PM, Mendez MF.

Soc Neurosci. 2019 May 7:1-10. doi: 10.1080/17470919.2019.1614478. [Epub ahead of print]

PMID:
31064266
17.

L3MBTL1 regulates ALS/FTD-associated proteotoxicity and quality control.

Lu J, Periz G, Lu YN, Tang Q, Liu Y, Zhang T, Shah Y, Thombre R, Aljumaah R, Li W, Mojsilovic-Petrovic J, Ji Y, Johnson K, Kalb R, Wang J.

Nat Neurosci. 2019 May 6. doi: 10.1038/s41593-019-0384-5. [Epub ahead of print]

PMID:
31061493
18.

Complex phenotype in a C9ORF72-positive patient with high-titer anti-glutamic acid decarboxylase antibodies: neuroimmunology meets neurogenetics.

Varvaressos S, Breza M, Marousi S, Printzou M, Georgoulis A, Papageorgiou E, Kartanou C, Karadima G, Tagaris G, Koutsis G, Tzartos JS.

Eur J Neurol. 2019 May 6. doi: 10.1111/ene.13926. [Epub ahead of print] No abstract available.

PMID:
31059159
19.

Pathogenic tau does not drive activation of the unfolded protein response.

Pitera AP, Asuni AA, O'Connor V, Deinhardt K.

J Biol Chem. 2019 May 3. pii: jbc.RA119.008263. doi: 10.1074/jbc.RA119.008263. [Epub ahead of print]

20.

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.

Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M, Bousiges O, Delaby C, Dumurgier J, Hugon J, Sablonnière B, Blanc F, Wallon D, Gabelle A, Laplanche JL, Bouaziz-Amar E, Peoc'h K; ePLM Group.

Clin Chim Acta. 2019 Apr 30. pii: S0009-8981(19)31840-6. doi: 10.1016/j.cca.2019.04.081. [Epub ahead of print]

PMID:
31051163

Supplemental Content

Loading ...
Support Center